Is there a case to be made for a global patent system? The example of plant biotechnology

Thomas Cottier, Marina Foltea and Dannie Jost

Papers from World Trade Institute

Abstract: abstract The assessment of patterns of patentability in plant biotechnology on the basis of existing statistics shows a considerable concentration of patents to a few countries, in particular the United States, Australia, Japan, China, Mexico, Brazil, Germany, Canada, New Zealand, South Korea, India, Spain and Hungary. These patterns suggest that there is a clear relationship between the choice ofpatent jurisdictions and the biotechnology regulatory framework. This observation of the geographic distribution of biotechnology patents lends credence to maintaining a system of territorial rights that allow for regulatory competition, but continuing the process of substantive patent law harmonization which potentially minimize trade barriers,

Date: 2012-06-29
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://www.wti.org/media/filer_public/cf/39/cf39dc ... er_jost_june2012.pdf First version (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:wti:papers:428

Access Statistics for this paper

More papers in Papers from World Trade Institute Contact information at EDIRC.
Bibliographic data for series maintained by Morven McLean ( this e-mail address is bad, please contact ).